Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In August, the company announced people who had obesity or were overweight without diabetes lost 12% of their body weight on average with the orforglipron pill after 72 weeks in a late-stage trial
Telehealth intake
Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options
Others inject both in the morning at different sites
US$ 28.27
US$ 23.40
US$ 26.76
US$ 27.62
US$ 29.05
